Maternal serum versus healthy donor GPIIb/IIIa (HPA-1a/a, -3a/a) |
|
|
Flow cytometric analysis |
IgG−/IgM− |
IgG−/IgM− |
MACE (AP2 capture of GPIIb/IIIa) |
− |
− |
Maternal serum versus healthy donor GPIIb/IIIa (HPA-1b/b, -2a/a, -3b/b, -5a/b, -15a/b) |
|
|
Flow cytometric analysis |
IgG−/IgM− |
IgG−/IgM− |
MACE (AP2 capture of GPIIb/IIIa) |
− |
− |
Maternal serum versus paternal GPIIb/IIIa |
|
|
Flow cytometric analysis |
IgG+/IgM+ |
IgG+/IgM− |
(AP2 capture of GPIIb/IIIa) |
− |
− |
MACE (AP2 capture of GPIIb/IIIa) |
+ |
+ |
Mother/Father blood type |
O/A1 |
O/A2B |
MACE reactivity after absorption of anti-A or anti-B |
+ |
+ |
Molecular characterization |
|
|
Exon/nucleotide change |
5/A584C |
12/C1942T |
Amino acid change |
K164T |
R622W |
Protein |
GPIIb |
GPIIIa |
NCBI dsSNP accession number |
rs142811900 |
rs139166528 |
Maternal serum vs. recombinant GPIIb/IIIa mutated to express paternal SNP |
|
|
Flow cytometric analysis with transfected CHO cell lines |
+ |
+ |
MACE with mutated GPIIb/IIIa (AP2/Tab capture) |
+ |
+ |